Home
Priorisitising interventions to minimise the burden of antimicrobial resistance
Our mission
The IMPACT AMR Network aims to improve the use of evidence to inform prioritisation decisions on the allocation of limited resources to interventions intending to reduce the AMR burden
Our goals
The IMPACT AMR Network will connect those with experience, expertise and responsibility for AMR interventions with a shared goal of prioritising efforts to minimise the burden of AMR. Through the activities of our workstreams, we will support progress towards a framework to identify the ‘best buy’ interventions to tackle AMR across One Health domains
Our approach
The IMPACT AMR Network aims to transcend boundaries between disciplines, sectors and actors affected by AMR and its interventions in different ways, through facilitating respectful exchange and a focus on collaborative problem-solving
DIVERSITY OF CONSTITUENTS
SHARED FOCUS
EQUALITY
Join the workstreams and become a co-creator of the outputs of the IMPACT AMR Network!
Subscribe for Network Updates and stay updated on our progress, future events, and further information
Follow us on our LinkedIn page, a space to interact with other members of our community and network!
Interested in becoming a co-creator of the outcomes and outputs of the IMPACT AMR Network? Signed up to the workstreams by clicking on the button and filling the form. You can find more information in our page specially dedicated to the workstreams.
Our Partners
Latest Recommended Resources
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England
Woods et al.
Applied Health Economics and Health Policy.
2025.
Using Large Language Models to Assist Antimicrobial Resistance Policy Development: Integrating the Environment into Health Protection Planning
Chen et al.
Environmental Science & Technology.
2025.
Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses
Donà et al.
The Lancet Microbe.
2025.
This Network is funded by UK Research and Innovation (UKRI) as part of its work to tackle infections (grant ref: BB/Z515644/1)
